US 6320074
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
expired A61PA61P17/00A61P3/02
Quick answer
US patent 6320074 (Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors) held by Ligand Pharmaceuticals Incorporated expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61P, A61P17/00, A61P3/02, A61P3/06, A61P35/00